Dr John David Anderson, MD | |
4469 Green Valley Road, Fairfield, CA 94534-1365 | |
(707) 864-8188 | |
(707) 864-8188 |
Full Name | Dr John David Anderson |
---|---|
Gender | Male |
Speciality | Urology |
Location | 4469 Green Valley Road, Fairfield, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235435637 | NPI | - | NPPES |
G19714 | Other | CA | MED BOARD OF CALIFORNIA PHYSICIAN & SURGEON |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208800000X | Urology | G19714 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr John David Anderson, MD 4469 Green Valley Road, Fairfield, CA 94534-1365 Ph: (707) 864-8188 | Dr John David Anderson, MD 4469 Green Valley Road, Fairfield, CA 94534-1365 Ph: (707) 864-8188 |
News Archive
Cardiovascular complications and hypoglycemia (low blood sugar) were common nonfatal complications in adults 60 years of age and older with diabetes, according to a study published by JAMA Internal Medicine, a JAMA Network publication.
Results of a Phase III study presented today at the EULAR 2011 Annual Congress show that at 6 months, 58.3 percent of patients who had previously not responded to treatment with DMARDs, achieved ACR20 response when treated with the novel oral Janus kinase inhibitor tofacitinib at 10mg BID compared to 31.2 percent in the placebo group. Significant improvements were also observed in the 5 mg BID dose.
Researchers have identified a protein necessary to maintain behavioral flexibility, which allows us to modify our behaviors to adjust to circumstances that are similar, but not identical, to previous experiences. Their findings, which appear in the journal Cell Reports, may offer new insights into addressing autism and schizophrenia—afflictions marked by impaired behavioral flexibility.
Now, in new research posted to the bioRxiv preprint server, scientists at Novavax, Inc. present a vaccine including recombinant influenza hemagglutinin (HA) antigen along with recombinant SARS-CoV-2 spike protein, with saponin Matrix-M adjuvant. Both have passed independent safety tests in phase 1 trials.
› Verified 4 days ago
Mark R Susskind, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1234 Empire St, Fairfield, CA 94533 Phone: 707-426-3911 Fax: 707-434-2043 | |
Herkanwal S. Khaira, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1860 Pennsylvania Ave Ste 200, 200, Fairfield, CA 94533 Phone: 707-646-4180 Fax: 707-646-4181 |